Firas Zahr, MD

Director, Interventional Cardiology
OHSU

Dr. Zahr is an Associate Professor in the Knight Cardiovascualt Institute of Oregon Health & Science University. He is the the director of Interventional Cardiology and Co-Director of the Structural Heart Disease program. His main research interest is minimally invasive therapies for valvular heart disease.

Disclosure(s): Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Presentation(s):

• Outcomes From a Randomized Comparison of Transcatheter Edge-to-Edge Repair Systems for Degenerative MR | The CLASP IID Trial and Registry

  Saturday, March 7, 2026
  4:10 PM - 4:18 PM EST

• How to Manage Tricuspid SLDA

  Saturday, March 7, 2026
  3:31 PM - 3:38 PM EST

• What is the Role of Heart Failure Interventional Devices in the Era of Advanced Medical Therapies

  Sunday, March 8, 2026
  9:31 AM - 9:39 AM EST

• The Journey to the Fourth Commercial TAVR Valve | Is it a Luxury or a Necessity?

  Sunday, March 8, 2026
  8:56 AM - 9:04 AM EST

• Does the Current Data Support the Uphill Trend of TMVR Technology?

  Sunday, March 8, 2026
  4:41 PM - 4:49 PM EST

• Panel Discussion | What Does the Future Hold for TMVR? Predictions for the Next 5 Years

  Sunday, March 8, 2026
  5:29 PM - 5:45 PM EST

• What Do the US and EU Guidelines Say (and Why)?

  Sunday, March 8, 2026
  4:08 PM - 4:16 PM EST

• Mitral Repair and Replacement | State of the Field

  Monday, March 9, 2026
  9:45 AM - 10:00 AM EST